29
Apr
2006
Suppressing Amyloid Beta
Permalink | View Comments (0) | Post Comment | Posted by Reason

The breadth of new approaches to developing the next generation of Alzheimer's therapies is a good thing; diversity and dynamism together indicate progress in medical science. Via the Globe and Mail: "TMP21 protein inhibits the production of a toxin in the brain called beta-amyloid, also known as Abeta, the main culprit in destroying brain cells in Alzheimer's patients. ... The protein appears to be very specific and only effects the toxin, but doesn't effect normal cell function." Attacking amyloid beta is one way forward, though scientists have shown that amyloid is not necessarily the real culprit. It's the most noteworthy late stage of a process best halted earlier, but at this point, too many people are suffering for lack of any port in the storm - a breadth of approaches is vital.

Link: http://www.theglobeandmail.com/servlet/story/RTGAM.20060427.wprotein0427/BNStory/specialScienceandHealth/home

Comments
Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.









Remember personal info?